Global Health Sciences Fund adds expertise to its investment team

Business Wire, June 6, 1996

DENVER--(BUSINESS WIRE)--June 6, 1996--INVESCO Trust Co., the investment advisor to The Global Health Sciences Fund, announced recently that Carol A. Werther has joined its investment team.

Werther brings to INVESCO a number of years of experience in health care investing, with a particlar focus on the biotechnology sector.

Between 1990 and 1994, Werther worked as a biotechnology analyst for Lehman Brothers and Cowen & Co. In 1994, Werther took a position with Rothschild Asset Management Ltd. as a portfolio manager specializing in biotechnology. Werther earned her BS from Cornell University, her MS from the University of Alabama in Birmingham and her MBA from New York University.

"INVESCO has a long tradition as a manager of health care portfolios. Carol is a valuable addition to the team and we are happy to have her on board. She will help us provide investors with the investment diligence and investment performance that they have grown to expect from INVESCO," said Dalton Sim, chairman and president of INVESCO Trust Co.

"Our only business is portfolio management. For that reason, we are committed to building the highest quality investment management team. The main beneficiaries of that strategy are the shareholders of The Global Health Sciences Fund," said Sim.

The Global Health Science Fund (NYSE:GHS) is a diversified, closed-end management investment company whose investment objective is to seek capital appreciation by investing substantially all of its assets in equity and related securities of U.S. and foreign companies principally engaged in the development, production or distribution of products or services relating to the health sciences.

CONTACT: INVESCO Trust Co., Denver

Buck Phillips, 303/930-6521

800/528-8765